Viromed Medical AG (ETR:VME)
Germany · Delayed Price · Currency is EUR 4.700
0.00 (0.00%)
At close: Oct 26, 2026
Viromed Medical AG Company Description
Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally.
The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections.
It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies.
The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was founded in 2021 and is based in Rellingen, Germany.
Viromed Medical AG
| Country | Germany |
| Founded | 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 17 |
Contact Details
Address: Hauptstraße 105 Rellingen, 25462 Germany | |
| Phone | 49 4101 809960 |
| Website | viromed-medical-ag.de |
Stock Details
| Ticker Symbol | VME |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A40ZVN7 |
| SIC Code | 5047 |
Key Executives
| Name | Position |
|---|---|
| Uwe Perbandt | Member of Management Board |